MedPath

Comparison of Propofol and Thiopental in the treatment of refractory Status Epilepticus

Phase 3
Conditions
Epilepsy.
Status epilepticus
Registration Number
IRCT138707231349N1
Lead Sponsor
Shiraz University of Medical Sciences,Vice chanceller for Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Refractory Status Epilepticus. Exclusion criteria: hypotension, hypoxia, sepsis, liver failure, renal failure, heart disease

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Convulsion control. Timepoint: During admission. Method of measurement: Time (hours) to stop convulsion.;Convulsion control. Timepoint: During admission (EEG every 24 hr). Method of measurement: Time (hours) to see burst suppression appearance on EEG.
Secondary Outcome Measures
NameTimeMethod
Complication of treatment (metabolic acidosis, fatty liver, hypoxia). Timepoint: blood gas analyses: every hour, blood chemicals: twice a day, others: every other day. Method of measurement: labratory tests.;Time of mechanical ventilation. Timepoint: During admission. Method of measurement: Time (hours) of mecahanical ventilation.;PICU stay. Timepoint: During admission. Method of measurement: Number of PICU admission days.
© Copyright 2025. All Rights Reserved by MedPath